Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2-Methoxydiol derivatives as new tubulin and HDAC dual-targeting inhibitors, displaying antitumor and antiangiogenic response
Moran Sun, Jinling Qin, Yingying Kang, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105625-105625
Closed Access | Times Cited: 16

Showing 16 citing articles:

The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 620-620
Open Access | Times Cited: 11
A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy
Weixin Zhang, Jiao Huang, Xin-Yi Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115673-115673
Closed Access | Times Cited: 20
Design, Synthesis and Mechanistic Study of New Dual Targeting HDAC/Tubulin Inhibitors
Mona S. El‐Zoghbi, Amr K.A. Bass, Gamal El‐Din A. Abuo‐Rahma, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 7, pp. 601-622
Open Access | Times Cited: 5
Dual-target inhibitors of colchicine binding site for cancer treatment
Lu Lu, Keke Li, Jiaxin Pu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116543-116543
Closed Access | Times Cited: 5
Recent Advancements in the Development of HDAC/Tubulin Dual-Targeting Inhibitors
Christine Tran, Abdallah Hamzé
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 341-341
Open Access
Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors
Camille Hauguel, Sarah Ducellier, Olivier Provot, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114573-114573
Open Access | Times Cited: 24
Overview of Class I HDAC Modulators: Inhibitors and Degraders
Ziqian Huang, Limei Zeng, Binbin Cheng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116696-116696
Closed Access | Times Cited: 3
A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma
Jacinta O. Pinho, Mariana Matias, Ana Godinho‐Santos, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 123011-123011
Open Access | Times Cited: 9
Recent developments of hydroxamic acid hybrids as potential anti-breast cancer agents
Xinran Cao, Yufeng Gong
Future Medicinal Chemistry (2024) Vol. 16, Iss. 5, pp. 469-492
Open Access | Times Cited: 2
Tubulin/HDAC dual-target inhibitors: Insights from design strategies, SARs, and therapeutic potential
Zhen Zhang, Rui Su, Juan Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117022-117022
Closed Access | Times Cited: 1
Discovery of a novel piperlongumine analogue as a microtubule polymerization inhibitor with potent anti-angiogenic and anti-metastatic efficacy
Jinling Qin, LI Hong-liang, Xuan Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114738-114738
Closed Access | Times Cited: 8
Adverse effects of 2-Methoxyestradiol on mouse oocytes during reproductive aging
Xiuying Jiang, Xiangning Xu, Bi‐Cheng Wang, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110277-110277
Closed Access | Times Cited: 6
The Development of HDAC and Tubulin Dual-Targeting Inhibitors for Cancer Therapy
Jing Nie, Huina Wu, Yepeng Luan, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 5, pp. 480-490
Closed Access | Times Cited: 2
Discovery of novel amide derivatives against VEGFR-2/tubulin with potent antitumor and antiangiogenic activity
Zhenling Liu, S.-Y. Mao, Huixia Li, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107679-107679
Closed Access
Dual-targeting inhibitors involving tubulin for the treatment of cancer
Prasanna Anjaneyulu Yakkala, Ähmed Kamal
Bioorganic Chemistry (2024) Vol. 156, pp. 108116-108116
Closed Access
Synthesis and antitumor activity of litseaone B analogues as tubulin polymerisation inhibitors
Wei Yang, Huining Peng, Yong Huang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2530-2539
Open Access
Page 1

Scroll to top